Growing out of the old self: management itself says the company has quietly become a different business, and the numbers
The model's full reasoning — Q1 2017 call → NOThe question asks whether management conveys that the company today is running on a different basis than its reported results and reputation were built on — that is, whether management describes the company as having crossed into being a different kind of business, while making clear that this change is not yet what the reported numbers or outside picture reflect. Let me analyze the transcript for evidence of both halves: (1) A CHANGE OF BASIS, ALREADY REAL: - Beth Hougen says: "With the approval of SPINRAZA late last year, Q1 was the first full quarter in which we added commercial revenues to our substantial base of R&D revenue." This indicates a shift from R&D revenue to commercial revenue. - She also says: "The addition of commercial revenue is a reflection of the evolution of our business and our progress towards sustained profitability." - Stan Crooke says: "The addition of commercial revenues from SPINRAZA royalties, coupled with our strong and growing base of R&D revenue, we're in the strongest financial position in the company's history." - Lynne Parshall says: "The success of SPINRAZA, along with the continued progress towards commercialization of volanesorsen and IONIS-TTRRx, should further enable our transition to a multiproduct profitable organization." (2) MANAGEMENT SAYS THE RECORD AND THE PERCEPTION LAG THE CHANGE: - Beth Hougen says: "You'll notice that we have modified the revenue section of our P&L to break out our commercial revenues from our R&D revenues." This suggests the financial statements now reflect the change. - She also says: "We're on track to meet our 2017 financial guidance of being breakeven or profitable at the operating line on a pro forma basis." - Stan Crooke says: "We're now closer than ever to our goal of becoming a profitable multiproduct company." However, let me look more carefully. The question asks whether management conveys that the company has crossed into being a different kind of business. The key elements: - The company has historically been an R&D company (Ionis Pharmaceuticals, developing antisense drugs, partnering with larger pharma). Now it's adding commercial revenue from SPINRAZA royalties. - Beth says: "Q1 was the first full quarter in which we added commercial revenues to our substantial base of R&D revenue." This is a change — the company now has commercial revenue, not just R&D revenue.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| SANG | Sangoma Technologies Corporation | Q2 2024 | 2024-02-08 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| CALX | Calix, Inc. | Q1 2023 | 2023-04-20 | C+ |
| WD | Walker & Dunlop, Inc. | Q2 2022 | 2022-08-09 | C+ |
| KD | Kyndryl Holdings, Inc. | Q4 2021 | 2022-03-01 | C+ |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| CAG | Conagra Brands, Inc. | Q2 2017 | 2016-12-22 | C+ |
CALX · Q1 2023 → YESThe question is whether management conveys that the company today is running on a different basis than what its reported results and reputation were built on. Both parts: a change of basis already rea...YES The transcript shows management describing the company as now operating on a fundamentally different basis—selling into a new market of broadband service providers building consolidated networks, shifting from a legacy cyclical model to sequential revenue through platforms, clouds, and managed services—while treating this as an accomplished reality today, not a future plan. They emphasize numbers like 988 BSP deployments, 865 cloud customers, and 334 managed services customers, along with three years of over 25% growth, as evidence of this new foundation already in place.
SANG · Q2 2024 → YESThe question is whether management conveys that the company today is running on a different basis than the one its reported results and reputation were built on. Both parts: a real change of basis alr...
WD · Q2 2022 → YESThe question is whether management conveys that the company today is running on a different basis than the company its reported results and reputation were built on. Specifically, two parts: a change ...